Alkermes Controlled Therapeutics Inc Waltham, MA - 02451

Alkermes Controlled Therapeutics Inc is categorized under Commercial Biotechnical Research in Waltham, MA and active since 1993.

Alkermes Controlled Therapeutics Inc was established in 1993, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Richard F Pops at the company’s single location by writing to 852 Winter St, Waltham, Massachusetts MA 02451 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Alkermes Controlled Therapeutics Inc
Contact Person: Richard F Pops
Address: 852 Winter St, Waltham, Massachusetts 02451
Website Address: alkermes.com
Annual Revenue (USD): Unknown
Founded: 1993
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Alkermes Controlled Therapeutics Inc was started in 1993 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Richard F Pops for inquiries that concern Alkermes Controlled Therapeutics Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Alkermes Controlled Therapeutics Inc can be found at the coordinates 42.405568,-71.27204 as well as the street address 852 Winter St in Waltham, Massachusetts 02451.

For its online presence, you may visit Alkermes Controlled Therapeutics Inc’s website at alkermes.com and engage with its social media outlets through on Twitter and on Facebook.